Abstract 5540: CCN5/WISP-2 prevents leptin-induced breast cancer cell growth and migration
In menopausal women, one of the important risk factors for breast cancer is obesity/adiposity. Despite multiple studies, the biological mechanism by which obesity influences the breast carcinogenic process is still unclear. It is evident from various studies that leptin, a 16 kDa protein hormone ove...
Gespeichert in:
Veröffentlicht in: | Cancer research (Chicago, Ill.) Ill.), 2011-04, Vol.71 (8_Supplement), p.5540-5540 |
---|---|
Hauptverfasser: | , , , , , |
Format: | Artikel |
Sprache: | eng |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | In menopausal women, one of the important risk factors for breast cancer is obesity/adiposity. Despite multiple studies, the biological mechanism by which obesity influences the breast carcinogenic process is still unclear. It is evident from various studies that leptin, a 16 kDa protein hormone over produced in obese people, plays a critical role in neovascularization and tumorigenesis in breast and other organs. Present studies demonstrate that leptin is able to induce proliferation and migration of estrogen receptor positive MCF-7 and ZR-75-1 breast tumor cell lines in a dose-dependent fashion but these effects are minimal in ER-negative MDA-MB-231 cells. Additionally, these studies found that leptin suppresses the transcriptional activation of anti-invasive gene CCN5/WISP-2. Although the suppression of CCN5 has no impact on the constitutive proliferation of these cells, it is critical for leptin-induced proliferation and necessary for the induction of in vitro migration of these cells because the addition of CCN5 recombinant protein into the media markedly inhibits the leptin-induced proliferation and migration. Collectively, these in vitro studies suggest that CCN5 may serve as a gatekeeper for leptin dependent breast carcinogenesis.
Citation Format: {Authors}. {Abstract title} [abstract]. In: Proceedings of the 102nd Annual Meeting of the American Association for Cancer Research; 2011 Apr 2-6; Orlando, FL. Philadelphia (PA): AACR; Cancer Res 2011;71(8 Suppl):Abstract nr 5540. doi:10.1158/1538-7445.AM2011-5540 |
---|---|
ISSN: | 0008-5472 1538-7445 |
DOI: | 10.1158/1538-7445.AM2011-5540 |